Molecular Partners Ag (MOLN) Change in Acquisitions & Divestments (2021 - 2026)
Molecular Partners Ag (MOLN) posted quarterly Change in Acquisitions & Divestments of $5132.3 for Q1 2026, down 91.48% year-on-year from $60206.1 in Q1 2025, and up 100.0% on a QoQ basis from -$111.2 million in Q3 2025.
Molecular Partners Ag (MOLN) Change in Acquisitions & Divestments (2021 - 2026) Analysis & Trends
Molecular Partners Ag (MOLN) has reported Change in Acquisitions & Divestments for 6 consecutive years, with $5132.3 the latest figure, recorded in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Molecular Partners Ag | 147.97 Mn | 147.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,132.28 |
| Mar 31, 2026 | 5,132.28 |
| Sep 30, 2025 | -111.23 Mn |
| Sep 30, 2025 | -111.23 Mn |
| Jun 30, 2025 | 107.55 Mn |
| Jun 30, 2025 | 107.55 Mn |
| Mar 31, 2025 | 60,206.12 |
| Mar 31, 2025 | 60,206.12 |
| Sep 30, 2024 | -171.03 Mn |
| Sep 30, 2024 | -171.03 Mn |
| Jun 30, 2024 | 164.02 Mn |
| Jun 30, 2024 | 164.02 Mn |
| Mar 31, 2024 | 90,131.97 |
| Mar 31, 2024 | 90,131.97 |
| Sep 30, 2023 | -182.81 Mn |
| Sep 30, 2023 | -182.81 Mn |
| Jun 30, 2023 | 179.77 Mn |
| Jun 30, 2023 | 179.77 Mn |
| Mar 31, 2023 | 94,688.22 |
| Mar 31, 2023 | 94,688.22 |